OFIX
Orthofix Medical Inc

231
Mkt Cap
$635.07M
Volume
147,997.00
52W High
$20.73
52W Low
$10.24
PE Ratio
-5.06
OFIX Fundamentals
Price
$16.08
Prev Close
$15.97
Open
$15.97
50D MA
$14.79
Beta
1.16
Avg. Volume
338,699.48
EPS (Annual)
-$3.30
P/B
1.39
Rev/Employee
$494,734.53
Loading...
Loading...
News
all
press releases
Orthofix to Participate in Upcoming Investor Conferences
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial...
Business Wire·13d ago
News Placeholder
More News
News Placeholder
Orthofix to Report Third Quarter 2025 Financial Results
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before...
Business Wire·14d ago
News Placeholder
FMS vs. OFIX: Which Stock Is the Better Value Option?
FMS vs. OFIX: Which Stock Is the Better Value Option?
Zacks·20d ago
News Placeholder
ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7
Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.
Zacks·25d ago
News Placeholder
FMS vs. OFIX: Which Stock Should Value Investors Buy Now?
FMS vs. OFIX: Which Stock Is the Better Value Option?
Zacks·3mo ago
News Placeholder
Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates
Orthofix (OFIX) delivered earnings and revenue surprises of +225.00% and +3.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates
Idexx (IDXX) delivered earnings and revenue surprises of +9.67% and +4.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2024, and provided...
Business Wire·8mo ago
News Placeholder
Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San...
Business Wire·8mo ago
News Placeholder
Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25...
Business Wire·9mo ago

Latest OFIX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.